4148 — All Cosmos Bio-Tech Holding Share Price
Last trade - 00:00- TWD2.89bn
- TWD2.68bn
- TWD2.46bn
- 78
- 45
- 53
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.14 | ||
| Price to Tang. Book | 1.14 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.16 | ||
| EV to EBITDA | 11.41 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.45% | ||
| Return on Equity | 4.73% | ||
| Operating Margin | 7.09% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 1,642.78 | 2,197.32 | 3,702.33 | 2,826.59 | 2,458.64 | n/a | n/a | 6.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +110.98 | +141.07 | +83 | -62.22 | -12.19 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
All Cosmos Bio-Tech Holding Corporation is a Malaysia-based investment holding company. It engages in a range of industries, divided into four areas: agriculture, waste reutilization, health care and pharmaceuticals, and research and development of microbials. Its businesses include bio-chemical fertilizers, health care & pharmaceuticals, waste reutilization, and microorganisms. Through its subsidiary, All Cosmos Industries Sdn. Bhd. (ACI), it manufactures and markets bio-organic and bio-chemical fertilizers. Its products are exported to Taiwan, Indonesia, Vietnam, China, Cambodia, and the Philippines. ACI produces over 30 different types of fertilizers for the Malaysian market as well as for the larger Asia Pacific region. It produces a range of industrial microbes, fungi, and viruses. The company also offers probiotics, mycelium cordyceps sinensis powders, and other products. Its subsidiaries include Sabah Softwoods Hybrid Fertiliser Sdn. Bhd., PT All Cosmos Indonesia, and others.
Directors
- Shih Hao Peng CHM
- Jingwei Shi CFO
- Chuifeng Lin OTH
- Jialin Peng DRC
- Shengqing Peng DRC
- Genzai Xu DRC
- Luzhang Zhang DRC
- Qianhai Zhu DRC
- Wenquan Li IND
- Ziwu Luo IND
- Yongcheng Yang IND
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- March 26th, 2010
- Public Since
- June 8th, 2017
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 64,034,000
- Address
- PLO 650, Jalan Keluli 7, PASIR GUDANG, 81700
- Web
- https://www.allcosmos.com/en/
- Phone
- +60 72523788
- Auditors
- Deloitte & Touche LLP
Upcoming Events for 4148
Similar to 4148
Acelon Chemicals & Fiber
Taiwan Stock Exchange
Amia Co
Taiwan Stock Exchange
Allied Supreme
Taiwan Stock Exchange
Asia Polymer
Taiwan Stock Exchange
BORETECH Resource Recovery Engineering Co
Taiwan Stock Exchange
FAQ
As of Today at 01:02 UTC, shares in All Cosmos Bio-Tech Holding are trading at TWD45.10. This share price information is delayed by 15 minutes.
Shares in All Cosmos Bio-Tech Holding last closed at TWD45.10 and the price had moved by -4.85% over the past 365 days. In terms of relative price strength the All Cosmos Bio-Tech Holding share price has underperformed the FTSE Developed Asia Pacific Index by -14.33% over the past year.
The overall consensus recommendation for All Cosmos Bio-Tech Holding is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe All Cosmos Bio-Tech Holding dividend yield is 1.11% based on the trailing twelve month period.
Last year, All Cosmos Bio-Tech Holding paid a total dividend of TWD0.50, and it currently has a trailing dividend yield of 1.11%.Looking ahead, shares in All Cosmos Bio-Tech Holding are due to go ex-dividend on 2025-08-14 and the next dividend pay date is 2025-09-05.
All Cosmos Bio-Tech Holding are due to go ex-dividend on 2025-08-14 and the next dividend pay date is 2025-09-05. The historic dividend yield on All Cosmos Bio-Tech Holding shares is currently 1.11%.
To buy shares in All Cosmos Bio-Tech Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TWD45.10, shares in All Cosmos Bio-Tech Holding had a market capitalisation of TWD2.89bn.
Here are the trading details for All Cosmos Bio-Tech Holding:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 4148
Based on an overall assessment of its quality, value and momentum All Cosmos Bio-Tech Holding is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in All Cosmos Bio-Tech Holding is TWD97.00. That is 115.08% above the last closing price of TWD45.10.
Analysts covering All Cosmos Bio-Tech Holding currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like All Cosmos Bio-Tech Holding. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -22.75%.
As of the last closing price of TWD45.10, shares in All Cosmos Bio-Tech Holding were trading -2.71% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The All Cosmos Bio-Tech Holding PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD45.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
All Cosmos Bio-Tech Holding's management team is headed by:
- Shih Hao Peng - CHM
- Jingwei Shi - CFO
- Chuifeng Lin - OTH
- Jialin Peng - DRC
- Shengqing Peng - DRC
- Genzai Xu - DRC
- Luzhang Zhang - DRC
- Qianhai Zhu - DRC
- Wenquan Li - IND
- Ziwu Luo - IND
- Yongcheng Yang - IND